ATE460425T1 - Histondeacetylaseinhibitor und verfahren zu dessen herstellung - Google Patents
Histondeacetylaseinhibitor und verfahren zu dessen herstellungInfo
- Publication number
- ATE460425T1 ATE460425T1 AT04746393T AT04746393T ATE460425T1 AT E460425 T1 ATE460425 T1 AT E460425T1 AT 04746393 T AT04746393 T AT 04746393T AT 04746393 T AT04746393 T AT 04746393T AT E460425 T1 ATE460425 T1 AT E460425T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- production
- histone deacetylase
- deacetylase inhibitor
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
- C07K5/126—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003177298 | 2003-06-20 | ||
PCT/JP2004/008924 WO2004113366A1 (ja) | 2003-06-20 | 2004-06-18 | ヒストン脱アセチル化酵素阻害剤およびその製造方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE460425T1 true ATE460425T1 (de) | 2010-03-15 |
Family
ID=33534930
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04746393T ATE460425T1 (de) | 2003-06-20 | 2004-06-18 | Histondeacetylaseinhibitor und verfahren zu dessen herstellung |
Country Status (6)
Country | Link |
---|---|
US (1) | US7662778B2 (de) |
EP (1) | EP1640380B1 (de) |
JP (1) | JP4550738B2 (de) |
AT (1) | ATE460425T1 (de) |
DE (1) | DE602004025935D1 (de) |
WO (1) | WO2004113366A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4274946B2 (ja) * | 2002-02-20 | 2009-06-10 | 国立大学法人九州工業大学 | ヒストン脱アセチル化酵素阻害剤およびその製造方法 |
JP2007262058A (ja) * | 2006-03-03 | 2007-10-11 | Tokyo Univ Of Science | 糸状菌の分化抑制剤 |
US8158587B2 (en) | 2006-09-05 | 2012-04-17 | Kyushu Institute Of Technology | Compound having histone deacetylase-inhibiting activity, and pharmaceutical composition comprising the compound as an active ingredient |
JP5756290B2 (ja) * | 2007-09-09 | 2015-07-29 | ユニバーシティ オブ フロリダ リサーチ ファウンデーション,インコーポレイテッド | 大環状化合物および治療方法 |
US8293513B2 (en) * | 2007-12-14 | 2012-10-23 | Georgetown University | Histone deacetylase inhibitors |
US20110123644A1 (en) * | 2008-04-11 | 2011-05-26 | University Of Florida Research Foundation | Macrocyclic compounds and methods of treatment |
US9874565B2 (en) * | 2013-06-21 | 2018-01-23 | Dana-Farber Cancer Institute, Inc. | Oncogene associated with human cancers and methods of use thereof |
CN109912686B (zh) * | 2019-03-13 | 2022-07-05 | 北京大学深圳研究生院 | 一种靶向hdac的稳定多肽类抑制剂及其用途 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5922837A (en) * | 1995-09-20 | 1999-07-13 | Merck & Co., Inc. | Antiprotozoal cyclic tetrapeptides |
KR20010023449A (ko) * | 1997-09-02 | 2001-03-26 | 나가시마 카쭈시게, 노미야마 아키히코 | 신규한 환상 테트라펩티드 유도체 및 그 의약 용도 |
JPH11130795A (ja) | 1997-10-29 | 1999-05-18 | Yamanouchi Pharmaceut Co Ltd | Ym−175201物質 |
EP1123309A2 (de) | 1998-10-13 | 2001-08-16 | Fujisawa Pharmaceutical Co., Ltd. | Zyklische tetrapeptide und deren verwendung als histone deacetylase inhibitoren |
JP4269041B2 (ja) | 1999-03-02 | 2009-05-27 | 国立大学法人九州工業大学 | 新規な環状テトラペプチド誘導体とその医薬用途 |
WO2001007042A1 (en) | 1999-07-23 | 2001-02-01 | Merck & Co., Inc. | Apicidin-derived cyclic tetrapeptides |
US20030078369A1 (en) * | 1999-07-23 | 2003-04-24 | Meinke Peter T. | Apicidin-derived cyclic tetrapeptides |
CA2317003A1 (en) | 2000-02-28 | 2001-08-28 | Hidenori Nakajima | Gene expression potentiator |
JP2001316283A (ja) | 2000-02-28 | 2001-11-13 | Yasushi Kaneda | 遺伝子発現増強剤 |
US20060229236A1 (en) | 2001-12-28 | 2006-10-12 | Fujisawa Pharmaceutical Co. Ltd. | Cyclic tetrapeptide compound and use thereof |
JP4274946B2 (ja) | 2002-02-20 | 2009-06-10 | 国立大学法人九州工業大学 | ヒストン脱アセチル化酵素阻害剤およびその製造方法 |
-
2004
- 2004-06-18 US US10/561,298 patent/US7662778B2/en not_active Expired - Fee Related
- 2004-06-18 DE DE602004025935T patent/DE602004025935D1/de not_active Expired - Fee Related
- 2004-06-18 EP EP04746393A patent/EP1640380B1/de not_active Not-in-force
- 2004-06-18 AT AT04746393T patent/ATE460425T1/de not_active IP Right Cessation
- 2004-06-18 WO PCT/JP2004/008924 patent/WO2004113366A1/ja active Application Filing
- 2004-06-18 JP JP2005507289A patent/JP4550738B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1640380A4 (de) | 2006-08-23 |
WO2004113366A1 (ja) | 2004-12-29 |
EP1640380A1 (de) | 2006-03-29 |
EP1640380B1 (de) | 2010-03-10 |
JP4550738B2 (ja) | 2010-09-22 |
JPWO2004113366A1 (ja) | 2007-09-20 |
DE602004025935D1 (de) | 2010-04-22 |
US7662778B2 (en) | 2010-02-16 |
US20070185071A1 (en) | 2007-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200500342A1 (ru) | Гетероциклические замещённые пиперазины для лечения шизофрении | |
ES2282685T3 (es) | Derivados de hidroxietilamina para el tratamiento de la enfermedad de alzheimer. | |
ATE461923T1 (de) | Substituierte 1h-benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren | |
NO20070606L (no) | Inhibitorer av IAP | |
DE602006016313D1 (de) | Biphenylderivate und ihre verwendung bei der behandlung von hepatitis c | |
BRPI0508464A (pt) | sulfonilpirróis | |
BRPI0409227B8 (pt) | "composto, composição farmacêutica, uso de um composto e processo para a preparação de um composto de fórmula (i)" | |
NO20050741L (no) | Ny fremgangsmate for syntesen og ny krystallinsk form av agomelatin og farmasoytiske sammensetninger inneholdende den | |
ATE536349T1 (de) | In der 2-stellung durch phenyl substituierte 1h- benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren | |
DK1480961T3 (da) | Glutaminylbaserede DPIV-inhibitorer | |
ATE440833T1 (de) | Antithrombotische diamide | |
WO2006063113A3 (en) | Ureas as factor xa inhibitors | |
ATE307810T1 (de) | Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren | |
CY1111327T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξυλοξεικου οξεος | |
ATE449776T1 (de) | Pyrroloä2,3-cüpyridinderivate | |
WO2006055434A3 (en) | Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease | |
CY1109740T1 (el) | Νεα μεθοδος συνθεσης παραγωγων της 1,3,4,5 -τετραϋδρο-2η- 3-βενζαζεπιν-2-ονης και εφαρμογη στη συνθεση της ιβαβραδινης και των αλατων προσθηκης της σε ενα φαρμακευτικως αποδεκτο οξυ | |
DE602004011255D1 (de) | Phosphinsäurederivate, inhibitoren von beta-sekretase zur behandlung von alzheimer-krankheit | |
CY1109569T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης | |
ATE445617T1 (de) | Chinolinderivat, dessen verwendung, herstellung und dieses enthaltendes arzneimittel | |
DE602004008959D1 (de) | Benzoäbüä1,4üdioxepinderivate | |
ATE466007T1 (de) | 5-substituierte indol-2-carbonsäureamidderivate | |
DE502006008710D1 (de) | Substituierte tetrahydroisochinoline als mmp-inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament | |
CY1109975T1 (el) | Παρα-αλκυλ-υποκατεστημενα αμιδια ν-(4-υδροξυ-3-μεθοξυ-βενζυλο) κιναμμωμικου οξεος και η χρησιμοποιηση τους για την παρασκευη φαρμακων | |
ATE460425T1 (de) | Histondeacetylaseinhibitor und verfahren zu dessen herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |